Parkman Healthcare Partners LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1777015 STAMFORD, CT

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,396,854

+$940,927 QoQ

Shares Held

85,062

-28.8% QoQ

Ownership

0.146%

of shares outstanding

% of Portfolio

0.48%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Parkman Healthcare Partners LLC holds $82,007,868 across 7 Drug Manufacturers - Specialty & Generic names.

#	Ticker	Company	Shares	Value (USD)
1	ANIP	Ani Pharmaceuticals Inc	202,907	$16,796,641
2	BCRX	Biocryst Pharmaceuticals Inc	1,624,279	$16,242,790
3	INDV	Indivior Pharmaceuticals, Inc.	364,269	$14,945,957
4	XERS	Xeris Biopharma Holdings, Inc.	1,807,621	$14,316,358
5	AMRX	Amneal Pharmaceuticals, Inc.	541,190	$9,367,998
6	AMLX	Amylyx Pharmaceuticals, Inc.	398,782	$7,162,124
7	VTRS	Viatris Inc	200,000	$3,176,000

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,396,854	85,062	-28.8%	Shares	Sole	2026-05-15
2023-12-31	$3,455,927	119,417	-13.6%	Shares	Sole	2024-02-14
2023-09-30	$3,809,402	138,172	-27.3%	Shares	Sole	2023-11-14
2023-06-30	$5,716,780	190,179	+44.2%	Shares	Sole	2023-08-11
2023-03-31	$4,777,939	131,878	+39.0%	Shares	Sole	2023-05-12
2022-12-31	$3,385,297	94,906	+5.8%	Shares	Sole	2023-02-13
2022-09-30	$3,036,649	89,709	+1.2%	Shares	Sole	2022-11-14
2022-06-30	$2,563,989	88,658	-18.6%	Shares	Sole	2022-08-12
2022-03-31	$3,521,393	108,954	+4.0%	Shares	Sole	2022-05-13
2021-12-31	$3,053,460	104,714	+4.3%	Shares	Sole	2022-02-11
2021-09-30	$2,678,068	100,415	0.0%	Shares	Sole	2021-11-12
2021-06-30	$3,091,777	100,415	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.